TCM
WST icon

Twin Capital Management’s West Pharmaceutical WST Stock Holding History

Twin Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Buy
+8,520
New +$2.6M 0.33% 71
2024
Q1 		– Sell
-1,830
Closed -$644K – 298
2023
Q4 		$644K Hold
1,830
– – 0.08% 206
2023
Q3 		$687K Sell
1,830
-154
-8% -$59.6K 0.1% 194
2023
Q2 		$759K Sell
1,984
-18
-0.9% -$6.43K 0.1% 195
2023
Q1 		$694K Sell
2,002
-132
-6% -$38.6K 0.09% 204
2022
Q4 		$502K Sell
2,134
-1,306
-38% -$309K 0.07% 242
2022
Q3 		$847K Sell
3,440
-11,803
-77% -$3.6M 0.11% 193
2022
Q2 		$4.61M Sell
15,243
-211
-1% -$68.7K 0.59% 38
2022
Q1 		$6.35M Sell
15,454
-1,080
-7% -$423K 0.68% 30
2021
Q4 		$7.75M Buy
16,534
+880
+6% +$379K 0.78% 23
2021
Q3 		$6.65M Sell
15,654
-1,850
-11% -$780K 0.68% 28
2021
Q2 		$6.29M Buy
17,504
+8,764
+100% +$2.9M 0.58% 42
2021
Q1 		$2.46M Buy
8,740
+1,340
+18% +$384K 0.25% 129
2020
Q4 		$2.1M Buy
7,400
+1,410
+24% +$396K 0.19% 141
2020
Q3 		$1.65M Buy
+5,990
New +$1.59M 0.15% 166
2018
Q4 		– Sell
-4,005
Closed -$494K – 328
2018
Q3 		$494K Buy
+4,005
New +$449K 0.02% 307

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Twin Capital Management's WST Position: Q2 2026 in Review

Twin Capital Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 8,520 shares worth $3.06M. The stake represents 0.33% of the portfolio and ranks #71 among its holdings. This is a return to the name: Twin Capital Management previously reported a position in WST as recently as Q4 2023.

Twin Capital Management first reported a position in WST in Q3 2018 and has held it in 16 quarters since. The position peaked at $7.75M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Twin Capital Management held 8,520 shares of West Pharmaceutical worth $3.06M as of Q2 2026.
  • West Pharmaceutical was a new Twin Capital Management position in Q2 2026.
  • West Pharmaceutical made up 0.33% of Twin Capital Management's portfolio in Q2 2026, its #71 holding.
  • Twin Capital Management first reported a position in West Pharmaceutical in Q3 2018 and has held it in 16 quarters since.
  • Twin Capital Management's West Pharmaceutical position peaked at $7.75M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Twin Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.